|
Match
|
Document |
Document Title |
|
|
US20140058340 |
Eyelid Margin Wipes Comprising Chemical Means For Temperature Adjustment
An eyelid margin wipe comprising chemical means for adjusting the temperature of the wipe relative to the ambient temperature. The wipe is particularly useful for treatment of disorders of the... |
|
|
US20130267610 |
NOVEL LIPID DIPEPTIDE AND GEL
There is provided a gelator that is capable of forming a gel by an extremely small amount of addition in a wide pH range from acidic to alkaline regions, and a gel having high environmental... |
|
|
US20130251644 |
Cyclodextrin-Based Microemulsions, and Dermatological Uses Thereof
Described herein are cyclodextrin-stabilized microemulsion systems useful for increasing the solubility, stability, bioavailability, or safety of an active agent for delivery to the skin. The... |
|
|
US20120264681 |
BUFFERED OPHTHALMIC COMPOSITIONS AND METHODS OF USE THEREOF
The present disclosure provides a buffered ophthalmic composition for formulation of topically administrable suspensions useful for treating eye disorders by promoting wound healing, delivery of... |
|
|
US20110046606 |
Catheter injectable depot compositions and uses thereof
Catheter injectable depot compositions are provided that include a bioerodible, biocompatible polymer, a solvent having miscibility in water of less than or equal to 7 wt. % at 25° C., in an... |
|
|
US20090035372 |
METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE OF AN ACTIVE SUBSTANCE
The present invention pertains to a sized product, which contains a drug, polyethylene oxide with a molecular weight of 2,000,000 or higher, and a specific size controlling agent for polyethylene... |
|
|
US20140335034 |
Consumer Products Comprising Silane-Modified Oils
A consumer product comprises silane-modified oil comprising a hydrocarbon chain selected from the group consisting of: a saturated oil, an unsaturated oil, and mixtures thereof; and at least one... |
|
|
US20130253015 |
Cyclodextrin-Based Microemulsions, and Dermatological Uses Thereof
Described herein are cyclodextrin-stabilized microemulsion systems useful for increasing the solubility, stability, bioavailability, or safety of an active agent for delivery to the skin. The... |
|
|
US20120064134 |
COLOR ENHANCEMENT UTILIZING UP CONVERTERS AND DOWN CONVERTERS
A light emitting composition including first color emitters and second color emitters. The first color emitters are configured to emit, upon exposure to an energy source, visible light at a target... |
|
|
US20110105620 |
ORGANIC COMPOUNDS
A solid pharmaceutical composition suitable for oral administration, comprising: (a) S 1 P receptor agonist; and (b) a sugar alcohol. |
|
|
US20080311182 |
MULTISTAGE DELIVERY OF ACTIVE AGENTS
Multistage delivery vehicles are disclosed which include a first stage particle and a second stage particle. The first stage particle is a micro or nanoparticle that contains the second stage... |
|
|
US20080107731 |
DPP IV INHIBITOR FORMULATIONS
The present invention relates to pharmaceutical compositions of DPP IV inhibitors with an amino group, their preparation and their use to treat diabetes mellitus. |
|
|
US20160228359 |
OPHTHALMIC COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC CONDITIONS
Compositions, and methods of using such compositions, useful for placement, for example injection, into the interior of human or animal eyes are provided. Such compositions include a therapeutic... |
|
|
US20120136021 |
OXIDATION-STABILIZED TAMPER-RESISTANT DOSAGE FORM
A thermoformed pharmaceutical dosage form having a breaking strength of at least 300 N, said dosage form comprisinga pharmacologically active ingredient (A),a free physiologically acceptable acid... |
|
|
US20120132204 |
UNIT DOSE DRY POWDER INHALER
An inhaler includes a first body member and a second body member fit closely together to form an inhaler body, and an outlet. The first body member has a medicament chamber containing a unit dose... |
|
|
US20110136912 |
OPHTHALMIC EMULSION
The present invention is directed to an ophthalmic emulsion. The emulsion has a unique combination of ingredients that promotes the stability of small oil droplets within the emulsion. The... |
|
|
US20090252767 |
Water dispersible enteric coating formulation of nutraceutical and pharmaceutical dosage forms
The present invention relates to formulations for use as enteric coatings. More particularly, the present invention relates to a formulation comprising a dry blend of food grade ingredients that... |
|
|
US20090104263 |
5-HT4 partial agonist pharmaceutical compositions
A solid pharmaceutical composition for oral administration comprising tegaserod in base or salt form in an amount of up to 10% by weight a bulking agent in an amount of 70 to 90% by weight a... |
|
|
US20140322282 |
Microcrystalline Cellulose Compositions
Ultra-fine microcrystalline cellulose compositions are disclosed which comprise co-attrited microcrystalline cellulose and a hydrocolloid. The compositions have a mean particle size of less than... |
|
|
US20130172374 |
SOLID COMPOSITION FOR CONTROLLED RELEASE OF IONIZABLE ACTIVE AGENTS WITH POOR AQUEOUS SOLUBILITY AT LOW PH AND METHODS OF USE THEREOF
A novel solid composition and methods for making and using the solid composition are provided. The solid composition comprises: (a) at least one active agent with a solubility of less than about... |
|
|
US20100144895 |
EMBOLIC COMPOSITIONS WITH NON-CYANOACRYLATE RHEOLOGY MODIFYING AGENTS
Compositions for embolization are disclosed herein. The compositions disclosed can have a matrix-forming component, a solid-aggregate material, and a rheology modifying agent, wherein the... |
|
|
US20100016443 |
METHOD FOR PREPARING PARTICLES COMPRISING METAL OXIDE COATING AND PARTICLES WITH METAL OXIDE COATING
The invention relates to a process for coating a solid, water-insoluble particulate matter, with a metal oxide comprising: (a) contacting the solid, water-insoluble particulate matter with an... |
|
|
US20150182473 |
TRANSDERMAL PATCHES WITH DISCRETE CARBON NANOTUBES
A transdermal patch comprising discrete open-ended carbon nanotubes is disclosed. |
|
|
US20150079173 |
FORMULATIONS DECREASING PARTICLE EXHALATION
Formulations have been developed for pulmonary delivery to treat or reduce the infectivity of diseases such as viral infections, especially tuberculosis, SARS, influenza and respiratory synticial... |
|
|
US20140308239 |
CHIMERIC CYTOKINE FORMULATIONS FOR OCULAR DELIVERY
Featured herein are vehicle formulations and formulations containing a chimeric cytokine designed for e.g., ocular delivery. |
|
|
US20120134956 |
Colloidal metal compositions and methods
The present invention comprises compositions and methods for delivery systems of agents, including therapeutic compounds, pharmaceutical agents, drugs, detection agents, nucleic acid sequences and... |
|
|
US20110171188 |
NON-THERMAL PLASMA FOR WOUND TREATMENT AND ASSOCIATED APPARATUS AND METHOD
The invention relates to a non-thermal plasma for treatment of a surface, particularly for the treatment of a wound (1), wherein the plasma comprises a partially ionized carrier gas and at least... |
|
|
US20090053290 |
TRANSDERMAL DRUG DELIVERY COMPOSITIONS AND TOPICAL COMPOSITIONS FOR APPLICATION ON THE SKIN
Transdermal delivery compositions and topical compositions for application to the skin are provided. The transdermal delivery composition includes at least two penetrants working synergistically... |
|
|
US20080214557 |
METHOD FOR PREPARATION OF PHARMACEUTICAL COMPOSITION HAVING IMPROVED DISINTEGRATABILITY AND PHARMACEUTICAL COMPOSITION MANUFACTURED BY SAME METHOD
There exists a strong desire both for pharmaceutical compositions which rapidly exhibit pharmacological effects without an increase in the size of the dosage form or a decline in quality due to... |
|
|
US20160279281 |
ORGANOPHOSPHOROUS, MULTIVALENT METAL COMPOUNDS, & POLYMER ADHESIVE INTERPENETRATING NETWORK COMPOSITIONS & METHODS
Certain small molecule amino acid phosphate compounds such as phosphoserine and certain multivalent metal compounds such as calcium phosphate containing cements have been found to have improved... |
|
|
US20130065885 |
ORAL THERAPEUTIC COMPOUND DELIVERY SYSTEM
The present invention relates generally to therapeutic formulations. More particularly, this present invention provides an oral delivery system for a therapeutic compound that is a base, a salt of... |
|
|
US20100040678 |
ORGANIC COMPOUNDS
The present invention provides various pharmaceutical compositions comprising an S1P receptor modulator, e.g. an S1P receptor agonist. In one aspect, there is provided a pharmaceutical composition... |
|
|
US20090226507 |
HYDROXIDE-RELEASING AGENTS AS SKIN PERMEATION ENHANCERS
A method is provided for increasing the permeability of skin or mucosal tissue to topically or transdermally administered pharmacologically or cosmeceutically active agents. The method involves... |
|
|
US20140171319 |
Aqueous Composition Comprising a Pesticide and a Base Selected from an Alkali Salt of Hydrogencarbonate
The invention relates to a liquid aqueous composition, which has a pH value of at least 7.0, comprising a pesticide and a base selected from an alkali salt of hydrogencarbonate; a method for... |
|
|
US20120308487 |
Carnallite Preparation and Uses Thereof in Edible Applications
The present invention relates to a Carnallite salt preparation useful in edible products, such as a food, beverage, dietary supplement, oral care, nutraceutical pet food, animal feed,... |
|
|
US20110288363 |
Biologically Enhanced Irrigants
Compositions, systems and methods utilizing engineered surgical irrigants providing delivery of components with therapeutic or other secondary benefits. Engineered irrigants provide targeted... |
|
|
US20130095147 |
SOL-GEL DERIVED BIOACTIVE GLASS POLYMER COMPOSITE
A bioactive sol-gel solution includes a biocompatible polymer, a gelable inorganic base material, and at least one calcium and phosphorous molecular species. The base material can be an alkoxide,... |
|
|
US20120295986 |
CALCIUM SEQUESTERING COMPOSITION
This invention relates to compositions which are capable of sequestering calcium ions and are derived in part from renewable carbohydrate feedstocks. The calcium sequestering compositions are... |
|
|
US20100113616 |
INHIBITION OF DISCOLORATION BY WASHING AND CLEANING AGENTS AND/OR COSMETIC AGENTS
Method of inhibiting discoloration in agents by incorporating iodide salt(s), preferably calcium, potassium and/or sodium iodides into the formulation of those agents. The method is particularly... |
|
|
US20090155325 |
FORMULATION AND PRODUCTS FOR PROMOTING SKIN CLEANLINESS AND HEALTH
The present disclosure generally relates to a formulation. More particularly, the formulation may be applied to skin and/or used in combination with a personal care product to improve absorbance... |
|
|
US20140275287 |
Compositions and Methods for Hemostasis
The present invention relates to water soluble and completely absorbable and/or physiologically degradable hemostatic compositions having a wax or wax-like base effective for use in tamponade... |
|
|
US20090177273 |
ANISOTROPIC NANOPOROUS COATINGS FOR MEDICAL IMPLANTS
The present invention relates to a process for fabricating a porous coatings with controlled structure in the micro and nano-size domain. In particular, but not exclusively, it relates to a... |
|
|
US20160136097 |
ULTRAFAST-DISINTEGRATING TABLET AND METHOD FOR MANUFACTURING SAME
An object of the present invention is to provide an orally disintegrating tablet (ultrafast-disintegrating tablet) having an extremely high disintegrability (short disintegration time), and a high... |
|
|
US20140294948 |
COMPOSITION AS AUXILIARY MEANS FOR ORAL MEDICATION
The invention relates in one aspect to a composition, specifically a jelly, the use of which composition as an auxiliary means is to ease the taking of oral medication in solid form, which... |
|
|
US20130156871 |
Nasal Wash Solution
A composition provides an isotonic nasal irrigation solution with pH less than about 7.0. The composition may be formed of a salt and a pH buffer and may include an additive. The composition may... |
|
|
US20100240770 |
Synthesis and use of colloidal III-V nanoparticles
A colloidal suspension of III-V semiconductor nanoparticles. |
|
|
US20100143481 |
METHOD OF PREPARING SOLID DOSAGE FORMS OF MULTI-PHASIC PHARMACEUTICAL COMPOSITIONS
Pharmaceutical formulations comprising a multi-phasic pharmaceutical composition, and an adsorbent carrier, where the pharmaceutical formulation is a solid dosage form. Methods for preparing such... |
|
|
US20090297615 |
NANOPARTICLES, METHODS OF MAKING SAME AND CELL LABELING USING SAME
There are disclosed polyhedral superparamagnetic nanoparticles and methods for making and using the nanoparticles. There are also disclosed coated and functionalized forms of the nanoparticles,... |
|
|
US20090041695 |
Compositions for making up keratinous materials
The present invention relates to a cosmetic composition comprising: a physiologically acceptable medium;monodisperse particles suitable for forming an ordered lattice of monodisperse particles on... |
|
|
US20080233206 |
COMPOSITIONS AND METHODS FOR ANTI-INFLAMMATORY TREATMENTS
The present invention relates to an improved method for treating a wide range of inflammatory disorders by administering a tetracycline compound together with an effective inhibitor of... |